{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:54:29Z","timestamp":1793145269539,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Norwegian Cancer Society","doi-asserted-by":"publisher","award":["182759-2016"],"award-info":[{"award-number":["182759-2016"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012750","name":"South-East Regional Health Trust, Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"The Norwegian Research Council","doi-asserted-by":"publisher","award":["250993"],"award-info":[{"award-number":["250993"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.hpb.2018.12.003","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T09:21:34Z","timestamp":1549876894000},"page":"1017-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT"],"prefix":"10.1016","volume":"21","author":[{"given":"B.I.","family":"R\u00f8sok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"H\u00f8st-Brunsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.W.","family":"Brudvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Carling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dorenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Lothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Bj\u00f8rnbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2018.12.003_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/bjs.9872","article-title":"Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases","volume":"102","author":"Simoneau","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/bjs.10256","article-title":"Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases","volume":"103","author":"Adam","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2018.12.003_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamasurg.2013.2126","article-title":"Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy","volume":"148","author":"Fischer","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/bjs.7580","article-title":"Two-stage hepatectomy for multiple bilobar colorectal liver metastases","volume":"98","author":"Narita","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00268-013-2401-2","article-title":"ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence","volume":"38","author":"Oldhafer","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SLA.0000000000002319","article-title":"RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases","volume":"269","author":"Brudvik","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib10","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.hpb.2018.12.003_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","article-title":"ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a scandinavian multicenter randomized controlled trial (LIGRO trial)","volume":"267","author":"Sandstrom","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1076681","article-title":"Standardized liver volumetry for portal vein embolization","volume":"25","author":"Ribero","year":"2008","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.hpb.2018.12.003_bib13","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/SLA.0b013e318265fd3e","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?","volume":"256","author":"Aloia","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","article-title":"Early survival and safety of ALPPS: first report of the International ALPPS Registry","volume":"260","author":"Schadde","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.surg.2016.10.032","article-title":"Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: a case-matched comparison with palliative systemic therapy","volume":"161","author":"Olthof","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2018.12.003_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.surg.2017.09.044","article-title":"Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy","volume":"163","author":"Wanis","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2018.12.003_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jso.24959","article-title":"Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases","volume":"117","author":"Dupre","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2018.12.003_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/bjs.10834","article-title":"Biomarkers in colorectal liver metastases","volume":"105","author":"Yamashita","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib19","article-title":"APC and PIK3CA mutational cooperativity predicts pathologic response and survival in patients undergoing resection for colorectal liver metastases","author":"Yamashita","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/bjs.9870","article-title":"Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases","volume":"102","author":"Brudvik","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib21","article-title":"Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases","author":"Chun","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib22","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/76162","article-title":"Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: a preliminary study","author":"Wojas-Krawczyk","year":"2018","journal-title":"Adv Clin Exp Med Offic Org Wroclaw Med Univ"},{"key":"10.1016\/j.hpb.2018.12.003_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/SLA.0b013e3182a5025a","article-title":"RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases","volume":"258","author":"Vauthey","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.12.003_bib24","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1245\/s10434-016-5187-2","article-title":"RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases","volume":"23","author":"Brudvik","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.12.003_bib25","article-title":"Is hepatectomy justified for BRAF mutant colorectal liver metastases?: a multi-institutional analysis of 1497 patients","author":"Gagniere","year":"2018","journal-title":"Ann Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19300048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19300048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:20:59Z","timestamp":1761265259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19300048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1365182X19300048"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2018.12.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}